Oniosome Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 18-12-2024
- Paid Up Capital ₹ 2.00 M
as on 18-12-2024
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.00 M
as on 18-12-2024
- Revenue 21.99%
(FY 2022)
- Profit -12.00%
(FY 2022)
- Ebitda 30.33%
(FY 2022)
- Net Worth 1.41%
(FY 2022)
- Total Assets 54.06%
(FY 2022)
About Oniosome Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company has closed loans amounting to ₹1.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Namita Malviya and Sarvesh Malviya serve as directors at the Company.
- CIN/LLPIN
U73200CH2010PTC032221
- Company No.
032221
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Oniosome Healthcare Private Limited offer?
Oniosome Healthcare Private Limited offers a wide range of products and services, including Manpower Service, Technical Consultancy Services, Pharmaceutical Services, Pharmaceutical Testing Services, Formulation Development Service, Bioanalytical Services, Product Development Research, Pharmaceutical Research Services, Chemical Testing Services, Analytical Testing Service.
Who are the key members and board of directors at Oniosome Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sarvesh Malviya  | Director | 11-May-2010 | Current |
| Namita Malviya | Director | 31-Mar-2011 | Current |
Financial Performance of Oniosome Healthcare.
Oniosome Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 21.99% increase. The company also saw a substantial fall in profitability, with a 12% decrease in profit. The company's net worth moved up by a moderate rise of 1.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oniosome Healthcare?
Unlock access to Oniosome Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 24 Jan 2018 | ₹1.00 M | Satisfied |
How Many Employees Work at Oniosome Healthcare?
Unlock and access historical data on people associated with Oniosome Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oniosome Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oniosome Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
